Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ranibizumab for Diabetic Vitreous Hemorrhage
NCT07690800Phase 4Completed
- Sponsor
- Benha University
- Start
- Apr 2025
- Primary completion
- Mar 2026
- Countries
- 1
01
Overview
A Phase 4 trial of ranibizumab in vitreous hemorrhage secondary to proliferative diabetic retinopathy (DVH), sponsored by Benha University. Started Apr 2025; status: completed.
02
Drugs
ranibizumab
03
Conditions
vitreous hemorrhage secondary to proliferative diabetic retinopathy (DVH)
Beyond the preview
Go deeper on NCT07690800.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07690800.